What is the best management strategy for high grade dysplasia in Barrett's oesophagus? A cost effectiveness analysis. - Wikidata - wikimedia - TriplyDB

What is the best management strategy for high grade dysplasia in Barrett's oesophagus? A cost effectiveness analysis.

What is the best management strategy for high grade dysplasia in Barrett's oesophagus? A cost effectiveness analysis.

http://www.wikidata.org/entity/Q43004712

about

Surgery versus radical endotherapies for early cancer and high-grade dysplasia in Barrett's oesophagus Three-tiered risk stratification model to predict progression in Barrett's esophagus using epigenetic and clinical features.Barrett's esophagus and the increasing role of endoluminal therapy.Photodynamic therapy of cancer: an update Photodynamic therapy for Barrett's esophagus with high-grade dysplasia.Endoscopic ablation is a cost-effective cancer preventative therapy in patients with Barrett's esophagus who have elevated genomic instability Long-term survival following endoscopic and surgical treatment of high-grade dysplasia in Barrett's esophagus.Photodynamic therapy for Barrett's esophagus with high-grade dysplasia: a cost-effectiveness analysis.A cost-utility analysis of ablative therapy for Barrett's esophagus.Photodynamic therapy for Barrett's esophagus: does light still have a role?Endoscopic therapies for Barrett's-associated dysplasia: a new paradigm for a new decade.Management of early-stage esophageal neoplasia (MESEN) consensus.Endoscopic versus surgical therapy for Barrett's esophagus neoplasia.Endoscopic mucosal resection: early experience in British Columbia.Endoscopic Mucosal Resection as the Primary Treatment for Barrett Esophagus With Dysplasia.The impact of flexible endoscopy in esophageal surgery.Cost-effectiveness analysis of endoscopic eradication therapy for treatment of high-grade dysplasia in Barrett's esophagus.Endoscopic therapy for Barrett's esophagus and early esophageal cancer: Where do we go from here?

P2860

Q24202793-1D7451FE-A329-4219-A3E6-B6B31BCAC945 Q33326627-C1BA15FC-5DE8-4FA2-93DF-89E1A7370A7F Q34408906-9B555AB9-152B-4DB9-936D-CB4FCC6DA9BD Q35532394-DF1CEE11-2E3E-444F-B5F1-48C3AA2DB41A Q36131795-5C6F6A63-61F4-4A9D-9EEC-445974AA9847 Q36921955-2D05DAC1-D9C2-49B5-A676-CED302ED6C97 Q37106236-C10316C1-D7CB-4CA7-ADE2-2CF55C724787 Q37133451-A7AE9DFD-08BA-48F5-9E22-2E0248D053D0 Q37219864-47E2833B-5703-4506-9A94-42668A0128CD Q37344276-36E11C84-45CC-4E4E-BC4F-9F41889E211C Q38014493-F7215FDC-01B0-44D5-9A15-74D518BB6D87 Q38150209-36280C2D-11C4-479A-A8CE-16629D5BBF7F Q38243713-1D0F757D-838E-4A56-A23B-AF2EBB1B40D2 Q40367247-E90E53DB-4F94-4140-9F86-2F049FFEDB56 Q40767513-8E4209D5-3CE3-4B4F-8484-7D4AF6637B8D Q41202627-1D25D370-8768-45B0-995D-58A1E6CEF018 Q48794382-375F0C44-BA37-4688-83BE-26DFF52E3164 Q57074640-8EA443D9-4080-4A36-BC23-F0BFDA085E1C

P2860

What is the best management strategy for high grade dysplasia in Barrett's oesophagus? A cost effectiveness analysis.

http://www.wikidata.org/entity/Q43004712

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh-hant

name

What is the best management st ...... A cost effectiveness analysis.

@en

What is the best management st ...... A cost effectiveness analysis.

@nl

type

label

What is the best management st ...... A cost effectiveness analysis.

@en

What is the best management st ...... A cost effectiveness analysis.

@nl

prefLabel

What is the best management st ...... A cost effectiveness analysis.

@en

What is the best management st ...... A cost effectiveness analysis.

@nl

P1433

Q43004712-41A73093-7E47-4CB3-973B-8D5AEE603EA8

P1476

Q43004712-863C9A85-467B-402F-AC88-D9816B3C1948

P2093

Q43004712-683D605D-0661-4854-B1C6-E407A4C13FC7

Q43004712-753599F9-CE1D-415C-AB2E-340A513D60EF

Q43004712-DB38D5DB-9F53-4945-80C8-DA63668F6F66

P2860

Q43004712-0D533F99-F350-4BA7-8242-707E9FA9C90C

Q43004712-174E10B1-E8EB-4532-B4B4-278B5F6EDE30

Q43004712-1C5B670F-E427-4DE3-8984-55AE6888097E

Q43004712-1DB57A9B-ED34-479F-B8FD-1B3A7B4D6ADC

Q43004712-2018AA84-9367-4E63-AAFE-8221A81A0B2E

Q43004712-2019A98F-715D-4E07-A1C1-44F1E5D68976

Q43004712-2246845B-9AF8-4444-9AF6-F7A89822F4AA

Q43004712-26636AA1-2E23-48E7-9424-175248B40961

Q43004712-283B0C3B-0D6E-4413-AAB2-EBAE1B968F2E

Q43004712-2DA75BCD-02B0-4CA3-BDA5-D7F7D7A4BD5B

P304

Q43004712-EE63848A-9DFB-430F-BFD5-97ED55A8DD5E

P31

Q43004712-51E0A0C8-CF25-46AB-9B75-F71091E77831

P356

Q43004712-41DF8D5D-4930-45AC-9D20-98B6AE24CC12

P407

Q43004712-B937E23F-49BF-4E62-BABB-28E02FE45CB9

P433

Q43004712-6E3C6733-BFCE-412F-9BDC-EAC3C446220F

P478

Q43004712-AE737F08-5F23-434A-A6EE-2E470AE86208

P50

Q43004712-9C49C98B-D236-43B9-9852-FFAFA923CABB

P577

Q43004712-96DD6486-3FAA-4C0E-AB05-37506C2C7B29

P5875

Q43004712-2C5796EA-2186-45EA-B4CF-E4625E259789

P698

Q43004712-4C2612C9-F18F-4848-931F-4B7080FD6596

P932

Q43004712-9F219AE9-DE5B-4CE6-B530-84CDB90E20C9

P356

GUT.2003.033837

P1433

P1476

What is the best management st ...... A cost effectiveness analysis.

@en

P2093

B F Overholt

http://www.w3.org/2001/XMLSchema#string

N J Shaheen

http://www.w3.org/2001/XMLSchema#string

P Sharma

http://www.w3.org/2001/XMLSchema#string

P2860

Results from the American Society for Gastrointestinal Endoscopy/U.S. Food and Drug Administration collaborative study on complication rates and drug use during gastrointestinal endoscopy

An update on strategies for eradication of Barrett's mucosa.

Eradication of dysplastic Barrett's oesophagus using photodynamic therapy: long-term follow-up.

Photodynamic therapy for dysplastic Barrett's oesophagus: a prospective, double blind, randomised, placebo controlled trial

Photodynamic therapy for Barrett's esophagus: follow-up in 100 patients.

Photodynamic therapy for Barrett's esophagus with dysplasia and/or early stage carcinoma: long-term results.

Variable pathologic interpretation of columnar lined esophagus by general pathologists in community practice.

Pulmonary embolism following laparoscopic antireflux surgery: a case report and review of the literature.

Is there publication bias in the reporting of cancer risk in Barrett's esophagus?

Dysplasia in short-segment Barrett's esophagus: a prospective 3-year follow-up.

P304

1736-1744

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/GUT.2003.033837

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

53

http://www.w3.org/2001/XMLSchema#string

P50

P577

2004-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8183516

http://www.w3.org/2001/XMLSchema#string

P698

15542506

http://www.w3.org/2001/XMLSchema#string

P932

1774325

http://www.w3.org/2001/XMLSchema#string